x
CME-Tagline

From Bedside to Webside: Providing Optimal Care for NVAF Patients via Telemedicine

CMEO Webcast

Premiere Date: Thursday, May 6, 2021

This activity offers CE credit for:

  1. Physicians (CME)
  2. Pharmacists (ACPE)
  3. ABIM (MOC)
  4. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Friday, May 6, 2022

Faculty


Mintu P. Turakhia, MD, MAS Mintu P. Turakhia, MD, MAS (Moderator)
Associate Professor
Executive Director, Center for Digital Health
Stanford University School of Medicine
Director of Cardiac Electrophysiology
VA Palo Alto Health Care System
Palo Alto, CA

Christian T. Ruff, MD, MPH Christian T. Ruff, MD, MPH 
Director, General Cardiology, Cardiovascular Division
Brigham and Women's Hospital
Associate Professor of Medicine, Harvard Medical School
Senior Investigator, TIMI Study Group
Boston, MA

Margot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPL Margot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPL 
Associate Professor
Department of Family and Community Medicine
Lewis Katz School of Medicine at Temple University
Philadelphia, PA

Statement of Need

When managing patients newly diagnosed with nonvalvular atrial fibrillation (NVAF), it is imperative for clinicians to discuss the diagnosis, evaluate individual stroke and bleeding risks, and use this information to guide therapeutic decisions. Counseling patients on a new NVAF diagnosis and discussing the need for stroke preventive therapy and available treatment options is a critical part of NVAF management that can be challenging when providing care via telemedicine.

This CME Outfitters BriefCase focuses on managing patients with NVAF via telemedicine, including discussion on treatment, clinical efficacy and safety of oral anticoagulants, selecting appropriate anticoagulation at the appropriate dose, applying the latest recommendations for patients who have undergone PCI, and how to implement best practices for a "webside manner" when providing virtual, telemedicine care.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Apply best practices for management of stroke risk in patients with NVAF when providing care via telemedicine.

The following learning objectives pertain only to those requesting CNE credit:

  • Summarize best practices for management of stroke risk in patients with NVAF when providing care via telemedicine.

Financial Support

Supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance

Target Audience

Primary care physicians, cardiologists, PAs, nurse practitioners, and pharmacists

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CPE Credit (Pharmacists):
ACPE CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.75 contact hours (0.075 CEUs) Universal Activity Number:
Enduring: 0376-0000-21-082-H01-P

Type: Knowledge-based

ABIM/MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Learning Format
Enduring material

Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.

MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Note to PAs: PAs may claim a maximum of 0.75 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Turakhia reports that he receives grants from the American Heart Association; Apple Inc.; Bayer; Boehringer Ingelheim; Bristol Myers Squibb Company; Cardiva Medical, Inc.; Janssen Pharmaceuticals, Inc.; and SentreHEART, Inc. He is a consultant for Abbott; BIOTRONIK, Inc.; Cardiva Medical, Inc.; iRhythm Technologies, Inc.; Johnson & Johnson; Medtronic; Milestone Pharmaceuticals, Inc.; MyoKardia, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; and Sanofi. He receives other financial or material support as an editor for JAMA Cardiology.

Dr. Ruff reports that he receives research grants to the TIMI Study Group through Brigham and Women's Hospital: Anthos Therapeutics; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo, Inc.; and National Institutes of Health. He is on Scientific Ad Boards and a consultant for Anthos Therapeutics; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; and Portola Pharmaceuticals, Inc.

Dr. Savoy has no disclosures to report.

Jeffrey Helfand, DO (peer reviewer) has no disclosures to report.

Mae Ochoa, RPh (peer reviewer) has no disclosures to report.

Maria Glukhovsky, PharmD (planning committee) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).


This document was last modified on:

BC-035-050621-90